PCAT1 was upregulated in docetaxel (DTX)-resistant PCa prostate cancer cells and in prostate cancer (PCa) patients, whereas PCa patients with higher serum PCAT1 levels had an unsatisfactory response to DTX chemotherapy. Here, PCAT1 is linked to prostate cancer.